Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 65

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 65
---
 Effective Time through the CVR. |

| • |     | Required Shareholder Approval —  The Arrangement Resolution requires approval of not                                                                                                                                                                                                                                                                                                                     
 less than (i) two-thirds of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting, and (ii) to the extent required under MI 61-101, a simple majority of the votes attached to Common Shares held by Shareholders present in person (virtually) or represented by proxy at the Special Meeting excluding for this purpose votes attached to Common 
 Shares held by persons described in items (a) through (d) of section 8.1(2) of MI 61-101.                                                                                                                                                                                                                                                                                                                |

| • |     | Ability to Respond to Acquisition Proposals Terms of the Arrangement — Under the terms                                                                                                                           
 of the Agreement, the Board remains able to respond to any Acquisition Proposals if it is determined that such Acquisition Proposal could reasonably be expected to lead to a Superior Proposal and to terminate |

36

| the Agreement if the Company receives a Superior Proposal prior to the approval of the Arrangement Resolution by the Shareholders, subject to payment of the Termination Payment. |

| • |     | Ability to Change its Recommendation — The Board’s right to make a Change of                                                                                     
 Recommendation to the Shareholders in the event of a Superior Proposal, subject to the Purchaser’s Right to Match Period and payment of the Termination Payment. |

| • |     | Negotiated Transaction — The Agreement is the result of the Transaction                                                                                                                                                                         
 Committee’s extensive strategic review process and negotiations with the Purchaser that were undertaken by the Company and its legal advisors with the oversight and participation of the Transaction Committee and its financial advisors. The 
 Transaction Committee believes the Arrangement is in the best interest of the Company and the Agreement includes terms and conditions that are reasonable in the judgment of the Transaction Committee.                                         |

| • |     | Dissent Rights — Registered Shareholders as of the Record Date who oppose the 
 Arrangement may exercise Dissent Rights in connection with the Arrangement.   |

The Transaction Committee and the Board also considered a number of potential issues and risks related to the Arrangement and the Agreement, including, among others:

| • |     | the risks to the Company and the Shareholders, if the Arrangement is not completed, including the costs to the 
 Company in pursuing the Arrangement;